MACON, Ga. — Gov. Brian Kemp’s amended budget for fiscal year 2026 includes a nearly $86 million one-time funding cut to Georgia’s Promise Scholarship program, following lower-than-expected ...

Harvard economist Roland Fryer details the findings of his research into creating genuine opportunity for every child in America, regardless of background. Photo: Free to Choose Network The veteran ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

The two largest U.S. oil companies, Chevron and Exxon Mobil, reported their lowest annual profits in years. By Rebecca F. Elliott Chevron’s chief executive praised Venezuela’s oil assets as the oil ...

ASH 2025 data on KLN-1010 suggest that off-the-shelf, in vivo CAR T therapy could significantly expand access to cellular therapy in multiple myeloma by reducing manufacturing, treatment delays, and ...

The construction industry is looking to AI and AI agents to make project managers’ lives easier, and eventually address an exodus of retiring talent. Construction-software firms are selling AI-powered ...

GRAND RAPIDS, Mich — There could be a new vaccine to prevent cancer. Companies Moderna and Merck said their clinical trials of a melanoma vaccine, combined with immunotherapy Keytruda, are lowering ...

Semaglutide shows promise in improving liver health and metabolic outcomes in MASH, enhancing steatohepatitis resolution and cardiometabolic measures. A large meta-analysis, published in Diabetology & ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

An experimental drug custom-made to target the genetic mutations of individual tumors showed promise in treating aggressive skin cancer, according to new results from a clinical trial announced ...

In recent months, the X account of the Venezuelan media outlet Polianalítica, followed by over 63,000 users, published a series of posts portraying Beijing as a steadfast political and security backer ...